Healthcare provider profile · identity verified

James Patrick Corrigan, D.O.

Family Practice · PHILADELPHIA, PA · NPI 1538157680

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	401	125
Amlodipine Besylate	Amlodipine Besylate	378	109
Losartan Potassium	Losartan Potassium	320	93
Levothyroxine Sodium	Levothyroxine Sodium	266	65
Lisinopril	Lisinopril	260	79
Pantoprazole Sodium	Pantoprazole Sodium	178	49
Metformin Hcl	Metformin Hcl	154	45
Famotidine	Famotidine	142	37
Omeprazole	Omeprazole	139	36
Gabapentin	Gabapentin	127	39
Metoprolol Succinate	Metoprolol Succinate	118	48
Tamsulosin Hcl	Tamsulosin Hcl	108	31
Rosuvastatin Calcium	Rosuvastatin Calcium	105	40
Albuterol Sulfate Hfa	Albuterol Sulfate	103	30
Hydrochlorothiazide	Hydrochlorothiazide	95	30
Metoprolol Tartrate	Metoprolol Tartrate	94	25
Zolpidem Tartrate	Zolpidem Tartrate	85	16
Methylprednisolone	Methylprednisolone	79	69
Furosemide	Furosemide	78	31
Simvastatin	Simvastatin	73	23
Pravastatin Sodium	Pravastatin Sodium	72	20
Sertraline Hcl	Sertraline Hcl	72	20
Glimepiride	Glimepiride	70	20
Allopurinol	Allopurinol	65	18
Lorazepam	Lorazepam	65	18
Januvia	Sitagliptin Phosphate	63	13
Eliquis	Apixaban	61	20
Montelukast Sodium	Montelukast Sodium	58	13
Escitalopram Oxalate	Escitalopram Oxalate	56	17
Clopidogrel	Clopidogrel Bisulfate	54	20
Jardiance	Empagliflozin	54	11
Fluoxetine Hcl	Fluoxetine Hcl	52	suppressed
Duloxetine Hcl	Duloxetine Hcl	51	suppressed
Bupropion Xl	Bupropion Hcl	49	12
Clonazepam	Clonazepam	45	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	11
Meloxicam	Meloxicam	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	14
Carvedilol	Carvedilol	37	13
Finasteride	Finasteride	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Alprazolam	Alprazolam	32	suppressed
Cephalexin	Cephalexin	32	31
Clindamycin Hcl	Clindamycin Hcl	32	28
Valsartan	Valsartan	32	suppressed
Atenolol	Atenolol	31	12
Clonidine Hcl	Clonidine Hcl	30	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Divalproex Sodium	Divalproex Sodium	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	27
Ibuprofen	Ibuprofen	28	15
Trulicity	Dulaglutide	28	suppressed
Diazepam	Diazepam	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Cefuroxime	Cefuroxime Axetil	26	21
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Azithromycin	Azithromycin	25	23
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	20
Ezetimibe	Ezetimibe	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Baclofen	Baclofen	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	14
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Glipizide	Glipizide	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Prednisone	Prednisone	18	suppressed
Trazodone Hcl	Trazodone Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	15
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Digoxin	Digoxin	17	suppressed
Invokana	Canagliflozin	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Ramipril	Ramipril	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Topiramate	Topiramate	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nystatin	Nystatin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error